Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems
Pharmaceutics · 20.05.2025 · 17 (5) · 673
DOI: 10.3390/pharmaceutics17050673 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.05.2025. Verfasst von Ghazala Muteeb und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, College of Applied Medical Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is an aggressive and prevalent liver cancer with a poor prognosis. Nanotechnology combined with natural products has emerged as a promising strategy to enhance HCC treatment efficacy. This review assesses the current literature on the application of nanotechnology in delivering natural products for HCC therapy. A comprehensive search was conducted in PubMed, Science Direct, Web of Science, and Google Scholar to identify relevant studies published up to the present articles focusing on nanotechnology-based drug delivery systems using natural products for HCC therapy, including different nanoparticle (NP) formulations and therapeutic interventions, were included. Natural products with anticancer properties have been encapsulated using various nanocarriers such as liposomes, polymeric nanoparticles, and quantum dots, which have improved drug stability, prolonged circulation time, and enhanced targeted delivery to HCC cells. These advancements have led to increased therapeutic efficacy and reduced side effects. Additionally, combining multiple natural products or integrating them with conventional therapies via nanocarriers enables personalized treatment approaches based on patient characteristics and molecular profiles. The integration of nanotechnology with natural products shows great potential for improving HCC treatment outcomes, representing a significant advancement in precision medicine for liver cancer and paving the way for more effective and personalized therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, College of Applied Medical Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
- Bio-Nanotechnology Department, Faculty of Nanotechnology, Cairo University, Giza 12613, Egypt.
- Biotechnology Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
- Faculty of Medicine, Galala University, Suez 43511, Egypt.
- Health Sector, Faculty of Science, Galala University, Suez 43511, Egypt.
ORCID-Profile: Ghazala Muteeb, Manar T El-Morsy, Mustafa Ali Abo-Taleb, Doaa S R Khafaga
Förderung
- Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia
Zitieren
APA
Muteeb, G., El-Morsy, M. T., Abo-Taleb, M. A., Mohamed, S. K., & Khafaga, D. S. R. (2025). Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems. Pharmaceutics, 17(5), 673. https://doi.org/10.3390/pharmaceutics17050673
Vancouver
Muteeb G, El-Morsy MT, Abo-Taleb MA, Mohamed SK, Khafaga DSR. Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems. Pharmaceutics. 2025;17(5):673. doi:10.3390/pharmaceutics17050673
BibTeX
@article{Muteeb2025,
author = {Muteeb, Ghazala and El-Morsy, Manar T and Abo-Taleb, Mustafa Ali and Mohamed, Salma K and Khafaga, Doaa S R},
title = {Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {5},
pages = {673},
doi = {10.3390/pharmaceutics17050673}
}
EUVIMED